全文获取类型
收费全文 | 1068篇 |
免费 | 79篇 |
专业分类
耳鼻咽喉 | 20篇 |
儿科学 | 38篇 |
妇产科学 | 65篇 |
基础医学 | 191篇 |
口腔科学 | 23篇 |
临床医学 | 103篇 |
内科学 | 207篇 |
皮肤病学 | 24篇 |
神经病学 | 91篇 |
特种医学 | 23篇 |
外国民族医学 | 1篇 |
外科学 | 125篇 |
综合类 | 4篇 |
预防医学 | 106篇 |
眼科学 | 15篇 |
药学 | 81篇 |
中国医学 | 1篇 |
肿瘤学 | 29篇 |
出版年
2023年 | 5篇 |
2022年 | 11篇 |
2021年 | 25篇 |
2020年 | 15篇 |
2019年 | 35篇 |
2018年 | 23篇 |
2017年 | 27篇 |
2016年 | 19篇 |
2015年 | 28篇 |
2014年 | 27篇 |
2013年 | 46篇 |
2012年 | 57篇 |
2011年 | 56篇 |
2010年 | 26篇 |
2009年 | 31篇 |
2008年 | 74篇 |
2007年 | 54篇 |
2006年 | 65篇 |
2005年 | 50篇 |
2004年 | 41篇 |
2003年 | 53篇 |
2002年 | 52篇 |
2001年 | 33篇 |
2000年 | 40篇 |
1999年 | 33篇 |
1998年 | 10篇 |
1997年 | 11篇 |
1996年 | 9篇 |
1995年 | 9篇 |
1994年 | 6篇 |
1993年 | 5篇 |
1992年 | 19篇 |
1991年 | 18篇 |
1990年 | 11篇 |
1989年 | 19篇 |
1988年 | 8篇 |
1987年 | 15篇 |
1986年 | 8篇 |
1985年 | 9篇 |
1984年 | 11篇 |
1983年 | 4篇 |
1982年 | 6篇 |
1981年 | 4篇 |
1979年 | 6篇 |
1978年 | 4篇 |
1977年 | 5篇 |
1976年 | 4篇 |
1973年 | 4篇 |
1971年 | 3篇 |
1970年 | 3篇 |
排序方式: 共有1147条查询结果,搜索用时 31 毫秒
31.
32.
Pedro Barrera‐Lpez Erika D. Prez‐Riveros Jos Moreno‐Montoya Silvia Marcela Ballesteros Sergio A. Valencia Jos A. De la Hoz‐Valle 《Journal of medical virology》2021,93(1):8-19
The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS‐Cov‐2) has led to the elaboration of multiple studies to increase knowledge and understanding, hence, having the ability to accomplish an adequate and timely diagnosis and give an optimal treatment according to the patient's condition. The clinical manifestations of COVID‐19 pose a series of challenges both in understanding and delimiting the disease secondary to the SARS‐CoV‐2 infection. This is due to the fact that the main axis of this disease is the endothelial compromise and the production of a “cytokine storm,” triggering multiple organ failure and death. Given that a complete understanding of its pathophysiology and clinical behavior has not yet been achieved, we wondered if coinfection with other respiratory viruses modifies its performance and outcomes described so far. A literature search was performed, obtaining 68 articles, of which 25 were analyzed. The analysis showed us that there is a high variety both in the types of associated infections and in the clinical behavior of patients and their outcomes. Therefore, we consider that the search for other infections should be performed exhaustively, especially in those cases that may be susceptible to treatment such as Influenza A, human immunodeficiency virus, or bacterial infections. As well as optimize the analysis of these cases and establish if there are characteristics that allow establishing the possibility of carrying an additional infection to that of SARS‐CoV‐2 and the implications for the management and prognosis of the patient. 相似文献
33.
Castano-Jaramillo Lina M. Yamazaki-Nakashimada Marco Antonio O’Farrill-Romanillos Patricia M. Muzquiz Zermeño David Scheffler Mendoza Selma C. Venegas Montoya Edna García Campos Jorge Alberto Sánchez-Sánchez Luz María Gámez González Luisa B. Ramírez López Jesús Moisés Bustamante Ogando Juan Carlos Vásquez-Echeverri Estefanía Medina Torres Edgar Alejandro Lopez-Herrera Gabriela Blancas Galicia Lizbeth Berrón Ruiz Laura Staines-Boone Aidé Tamara Espinosa-Padilla Sara Elva Segura Mendez Nora Hilda Lugo Reyes Saul O. 《Journal of clinical immunology》2021,41(7):1463-1478
Journal of Clinical Immunology - Patients with inborn errors of immunity (IEI) have a compromised or inappropriate immune response. Although they might be considered a high-risk group for severe... 相似文献
34.
Abundes A Rivera Jde J Arizmendi E Farell J Ledesma M Montoya S 《Revista espa?ola de cardiología》2002,55(11):1205-1208
BACKGROUND AND OBJECTIVES: We evaluated the technical and clinical results of implantation of the Atlas stent, the hospital stay, and the short and long-term clinical and angiographic outcome. PATIENTS AND METHOD: The study included 169 patients (60.1 10.8 year-old), 60.3% of which had acute coronary syndromes and complex lesions. Immediate success was achieved in 98% of cases. The clinical follow-up in 85.7% of the patients at 14.3 6.8 months, revealed that 89% remained free of adverse events and most (94.4%) were functional class I of the CCS. Angiographic follow-up at 8.4 4.1 months of 40.9% of the cases revealed restenosis in 27.9%. There were 2 cases of subacute thrombosis. CONCLUSIONS: The application of the Atlas stent in patients with a diverse clinical spectrum demonstrated good immediate and long term results, with a rate of restenosis similar to that of other stents available on the market. 相似文献
35.
Development changes in the human cardiac isomyosin distribution: an immunohistochemical study using monoclonal antibodies 总被引:4,自引:0,他引:4
With monoclonal antibodies (Mab) specific for myosin heavy chain (MHC) isozymes, we have investigated the isomyosin content of atrial, ventricular and conductive fibers of 19 human fetuses (ranging from 14-36 weeks of gestation) and 3 newborns (2 days-2 weeks). In addition, the conduction system of 2 human adult hearts was studied. The fetal atrium is composed mostly of alpha-MHC during the first 23 weeks of gestation. beta-MHC is already expressed as traces at 14 weeks of gestation, and its expression increases progressively until birth, resulting in a great augmentation in beta-MHC. During this course, beta-MHC always predominates in certain areas (the crista terminalis and the interatrial septum) but not in other areas (the auricles). Preceding birth, the fetal ventricle is composed mostly of beta-MHC. From 14 weeks of gestation to birth, alpha-MHC is expressed in very rare fibers. Then, after birth, a large number of fibers simultaneously synthesize alpha-MHC. The AV node and His bundle system were labelled with anti-alpha and anti-beta Mab in fetal, newborn, and adult hearts with a double gradient of distribution: spatial (a higher proportion of alpha-containing fibers in the AV node than in the distal portion of the bundle of branches) and temporal (a higher proportion of alpha-containing fibers at a given point in fetal development than in the adult heart). One of the twenty-five hearts studied had an isomyosin distribution pattern not accorded to its age. Interestingly, it was clinically diagnosed as having idiopathic hypertrophic cardiomyopathy. 相似文献
36.
C. Baquero‐Montoya M.C. Gil‐Rodríguez M.E. Teresa‐Rodrigo M. Hernández‐Marcos G. Bueno‐Lozano I. Bueno‐Martínez S. Remeseiro R. Fernández‐Hernández M. Bassecourt‐Serra M. Rodríguez de Alba E. Queralt A. Losada B. Puisac F.J. Ramos J. Pié 《Clinical genetics》2014,85(5):446-451
The disorders caused by mutations in genes encoding subunits and accessory proteins of cohesin complex are collectively termed as cohesinopathies. The best known cohesinopathy is Cornelia de Lange Syndrome (CdLS), which is a multisystem developmental disorder characterized by facial dysmorphism, limb malformations, growth and cognitive impairment. Mutations in five genes, encoding subunits of the cohesin complex (SMC1A, SMC3, RAD21) and its regulators (NIPBL, HDAC8), are responsible for ~70% of CdLS cases. We describe a 16‐year‐old boy with facial dysmorphism, growth retardation, intellectual disability, hirsutism and small hands, who has a small Supernumerary Marker Chromosome (sSMC) present in mosaic form. sSMC is composed of two duplicated segments encompassing 17 genes including SMC1A gene, at the regions Xp11.22 and Xp11.21q11.1. Clinical comparison between our patient with a previously reported individual with a SMC1A duplication and four male carriers of similar sSMC reported in databases, suggest that they all share clinical features related to cohesinopathies. Although our patient does not have the classical CdLS craniofacial phenotype, he has pre and postnatal growth retardation, intellectual disability and mild musculoskeletal anomalies, features commonly seen in patients with cohesinopathies. 相似文献
37.
38.
Micek MA Blanco AJ Carlsson J Beck IA Dross S Matunha L Seidel K Montoya P Gantt S Matediana E Jamisse L Gloyd S Frenkel LM 《The Journal of infectious diseases》2012,205(12):1811-1815
Single-dose nevirapine (sdNVP) given to prevent mother-to-child-transmission of HIV-1 selects NVP-resistance. Short-course zidovudine (ZDV) was hypothesized to lower rates of NVP-resistance. HIV-1 infected pregnant women administered sdNVP with or without short-course ZDV were assessed for HIV-1 mutations (K103N, Y181C, G190A, and V106M) prior to delivery and postpartum. Postpartum NVP-resistance was lower among 31 taking ZDV+sdNVP compared to 33 taking only sdNVP (35.5% vs. 72.7%; χ2 P = .003). NVP mutants decayed to <2% in 24/35 (68.6%) at a median 6 months postpartum, with no differences based on ZDV use (logrank P = .99). Short-course ZDV was associated with reduced NVP-resistance mutations among women taking sdNVP. 相似文献
39.
Thrombotic thrombocytopenic purpura (TTP) is a rare disorder that most often arises from inhibition of the enzyme ADAMTS13 by autoantibodies. This provides the rationale for the use of rituximab, an anti-CD20 monoclonal antibody, as an effective treatment. Multiple reports have indicated success employing it in patients with TTP, but only a few have reported its use during remission as a prophylaxis to prevent a relapse. Herein, we report the case of a patient with chronic relapsing TTP who was successfully treated with prophylactic rituximab. We also provide a review of the literature on this topic. 相似文献
40.